Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Reserpine (N1867): Workflow Guidelines for Research Use

    2026-06-10

    Reserpine (N1867): Workflow Guidelines for Research Use

    What This Product Solves

    Reserpine, chemically known as 3,20-Yohimban-16-carboxylic acid methyl ester, is a bioactive natural product widely utilized for research involving neurotransmitter depletion, antihypertensive mechanism analysis, and neuropharmacology. Extracted from Rauvolfia species and supplied as a highly pure compound (>98.8% by HPLC and NMR), Reserpine enables reliable modulation of monoaminergic pathways in controlled experimental systems. Its use is critical in laboratories requiring standardized, reproducible depletion of neurotransmitters to model neurophysiological and vascular processes relevant to hypertension and related pharmacological studies. This product is strictly for research purposes and is inappropriate for any diagnostic or clinical applications, including long-term biological studies or animal use outside the research context.

    Protocol Parameters

    • Solubility (DMSO): ≥13 mg/mL with gentle warming | applicable to preparation of concentrated stock solutions for in vitro assays | rationale: DMSO provides reliable solubilization for workflow reproducibility while avoiding precipitation | source_type: product dossier (Reserpine)
    • Storage temperature: -20°C (sealed, cool, dry) | applicable to compound stability and prevention of hydrolysis or degradation | rationale: Maintains compound integrity for consistent experimental results | source_type: product dossier
    • Solution stability: Use freshly prepared solutions; avoid long-term storage | applicable to all workflows involving solution-phase Reserpine | rationale: Minimizes risk of compound breakdown and variability in dose delivery | source_type: product dossier
    • Purity validation: >98.8% (HPLC/NMR) | applicable to experiments requiring quantitative and qualitative reliability | rationale: High purity ensures negligible interference from related alkaloids | source_type: product dossier
    • Shipping conditions: Blue ice (small molecules) | applicable to inter-lab transfer and initial receipt | rationale: Maintains low temperature and prevents degradation in transit | source_type: product dossier

    Workflow Setup and QC Checklist

    • Compound Receipt: Inspect shipment on arrival; confirm blue ice is present and product is cold. Immediately move Reserpine to -20°C storage to avoid thermal stress.
    • Stock Solution Preparation: Use anhydrous DMSO and gentle warming (not exceeding 37°C) to dissolve Reserpine up to the recommended solubility limit. Vortex thoroughly to ensure complete dissolution; filter if particulate matter remains.
    • Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles. Clearly label vials with concentration, preparation date, and storage conditions.
    • QC of Stocks: Visually inspect for precipitation before use. Optional: verify concentration by UV absorbance or HPLC, referencing the high-purity standard.
    • Experimental Use: Only use freshly thawed, single-use aliquots. Discard any unused solution after each experiment to prevent variability.
    • Documentation: Record lot number, preparation details, and storage logs in laboratory notebook or digital LIMS.

    For detailed technical workflow parameters and reproducibility practices, see the internal article "Reserpine (SKU N1867): Workflow Parameters for Lab Use", which outlines integration into routine neurotransmitter depletion and neuropharmacology assays. For specific guidance on maintaining compound integrity during neuropharmacology research, refer to "Technical Guide for Neuropharmacology Workflows".

    Common Failure Modes and Fixes

    • Incomplete Dissolution: If Reserpine does not fully dissolve in DMSO, gently warm and vortex. Do not use water or ethanol, as the compound is insoluble in these solvents and will precipitate.
    • Precipitation During Assay: If precipitation is observed after dilution, ensure DMSO concentration is sufficient and solutions are freshly prepared. Avoid long incubation at room temperature before use.
    • Degraded Compound: Degradation may occur if solutions are stored for prolonged periods or exposed to repeated freeze-thaw cycles. Always use freshly thawed aliquots and store dry powder at -20°C.
    • Batch-to-Batch Variability: Track lot numbers and record all preparation steps. Utilize high-purity Reserpine to minimize variability.

    Scope and Limitations

    Reserpine (N1867) is validated for research workflows involving neurotransmitter depletion, antihypertensive mechanism studies, and neuropharmacology research. It is not suitable for diagnostic, therapeutic, or veterinary applications (including equine studies) and should not be applied in vivo unless explicitly validated in the research context. Long-term storage of solutions is discouraged due to the risk of degradation. The compound's insolubility in water and ethanol restricts its use to DMSO-based workflows, and alternative solvents are not recommended without further validation. Researchers should consult the product information for additional details and technical documentation from APExBIO.

    Conclusion

    Reserpine (SKU N1867) offers a well-characterized, high-purity research tool for controlled neurotransmitter depletion and analysis of antihypertensive mechanisms. Its defined solubility and storage requirements support reproducibility in neuropharmacology workflows. By adhering to precise preparation, storage, and QC protocols, researchers can minimize variability and maximize data integrity. For further product specifications and workflow recommendations, consult the APExBIO Reserpine product page.